Trinka S. Coster

1.3k total citations
20 papers, 913 citations indexed

About

Trinka S. Coster is a scholar working on Endocrinology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Trinka S. Coster has authored 20 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, 5 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Trinka S. Coster's work include Escherichia coli research studies (8 papers), Vibrio bacteria research studies (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Trinka S. Coster is often cited by papers focused on Escherichia coli research studies (8 papers), Vibrio bacteria research studies (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Trinka S. Coster collaborates with scholars based in United States, Israel and Thailand. Trinka S. Coster's co-authors include David N. Taylor, Kevin Killeen, Andrew F. Trofa, John J. Mekalanos, Jerald Sadoff, Julie Kenner, David T. Beattie, Malabi M. Venkatesan, Thomas L. Hale and Dani Cohen and has published in prestigious journals such as The Lancet, Circulation and CHEST Journal.

In The Last Decade

Trinka S. Coster

20 papers receiving 875 citations

Peers

Trinka S. Coster
Ana A. Weil United States
K. Ramotar Canada
Claudine E. Fasching United States
Abu Tholib Aman Indonesia
Decy Subekti Indonesia
A. T. Dawkins United States
Trinka S. Coster
Citations per year, relative to Trinka S. Coster Trinka S. Coster (= 1×) peers Narain H. Punjabi

Countries citing papers authored by Trinka S. Coster

Since Specialization
Citations

This map shows the geographic impact of Trinka S. Coster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trinka S. Coster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trinka S. Coster more than expected).

Fields of papers citing papers by Trinka S. Coster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trinka S. Coster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trinka S. Coster. The network helps show where Trinka S. Coster may publish in the future.

Co-authorship network of co-authors of Trinka S. Coster

This figure shows the co-authorship network connecting the top 25 collaborators of Trinka S. Coster. A scholar is included among the top collaborators of Trinka S. Coster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trinka S. Coster. Trinka S. Coster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naranjo, Daniel, et al.. (2024). Testing the Feasibility of a Digital Point of Care Solution for the Trusted Near Real-Time Bidirectional Exchange of Novel and Informative Adverse Event Information. Therapeutic Innovation & Regulatory Science. 59(1). 124–134. 1 indexed citations
2.
Taylor, Lockwood G., et al.. (2015). Development of a mother-child database for drug exposure and adverse event detection in the Military Health System. Pharmacoepidemiology and Drug Safety. 24(5). 510–517. 12 indexed citations
3.
Meyer, Tamra E., Lockwood G. Taylor, David J. Graham, et al.. (2012). Neuropsychiatric events in varenicline and nicotine replacement patch users in the M ilitary H ealth S ystem. Addiction. 108(1). 203–210. 38 indexed citations
4.
Villines, Todd C., et al.. (2012). Abstract 14877: Dabigatran versus Warfarin Among Patients with Atrial Fibrillation: Real-World Post-Market Results. Circulation. 126. 4 indexed citations
5.
Robb, Melissa A., et al.. (2012). Active Surveillance of Postmarket Medical Product Safety in the Federal Partners' Collaboration. Medical Care. 50(11). 948–953. 8 indexed citations
6.
Taylor, Lockwood G., et al.. (2012). Acetaminophen overdose in the Military Health System. Pharmacoepidemiology and Drug Safety. 21(4). 375–383. 5 indexed citations
7.
Keiser, Paul B., Trinka S. Coster, Mark B. Stoddard, et al.. (2010). A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine. 28(43). 6970–6976. 55 indexed citations
8.
Coster, Trinka S., M K Wolf, Eric R. Hall, et al.. (2006). Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coli. Infection and Immunity. 75(1). 252–259. 36 indexed citations
9.
Coster, Trinka S., et al.. (2005). Data mining clinical records to detect adverse events. Clinical Pharmacology & Therapeutics. 77(2). P1–P1. 1 indexed citations
10.
Katz, David, Trinka S. Coster, Marcia K. Wolf, et al.. (2004). Two Studies Evaluating the Safety and Immunogenicity of a Live, Attenuated Shigella flexneri 2a Vaccine (SC602) and Excretion of Vaccine Organisms in North American Volunteers. Infection and Immunity. 72(2). 923–930. 70 indexed citations
11.
Kanesa-thasan, Niranjan, Robert Edelman, C O Tacket, et al.. (2003). PHASE 1 STUDIES OF WALTER REED ARMY INSTITUTE OF RESEARCH CANDIDATE ATTENUATED DENGUE VACCINES: SELECTION OF SAFE AND IMMUNOGENIC MONOVALENT VACCINES. American Journal of Tropical Medicine and Hygiene. 69(6_suppl). 17–23. 45 indexed citations
12.
Hoyt, Reed W., Jaques Reifman, Trinka S. Coster, & Mark J. Buller. (2002). Combat medical informatics: present and future.. PubMed. 335–9. 52 indexed citations
13.
Coster, Trinka S., et al.. (1999). Novel self-sampling culture method to monitor excretion of live, oral Shigella flexneri 2a vaccine SC602 during a community-based phase 1 trial. Journal of Laboratory and Clinical Medicine. 134(2). 141–146. 5 indexed citations
14.
Coster, Trinka S., Charles W. Hoge, Antoinette B. Hartman, et al.. (1999). Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602. Infection and Immunity. 67(7). 3437–3443. 179 indexed citations
15.
Brueckner, Ralf P., et al.. (1998). Prophylaxis of Plasmodium falciparum Infection in a Human Challenge Model with WR 238605, a New 8-Aminoquinoline Antimalarial. Antimicrobial Agents and Chemotherapy. 42(5). 1293–1294. 69 indexed citations
16.
Killeen, Kevin, David T. Beattie, David R. Spriggs, et al.. (1995). Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype. The Lancet. 345(8955). 949–952. 110 indexed citations
17.
Kenner, Julie, Trinka S. Coster, David N. Taylor, et al.. (1995). Peru-15, an Improved Live Attenuated Oral Vaccine Candidate for Vibrio cholerae O1. The Journal of Infectious Diseases. 172(4). 1126–1129. 103 indexed citations
18.
Mekalanos, John J., Matthew K. Waldor, Claudette L. Gardel, et al.. (1995). Live cholera vaccines: perspectives on their construction and safety. 93(4). 255–262. 16 indexed citations
19.
Taylor, David N., Kevin Killeen, Julie Kenner, et al.. (1994). Development Of A Live, Oral, Attenuated Vaccine Against El Tor Cholera. The Journal of Infectious Diseases. 170(6). 1518–1523. 88 indexed citations
20.
Coster, Trinka S., et al.. (1994). Coronary Artery Fistula Diagnosed by Transesophageal Echocardiography. CHEST Journal. 105(3). 959–961. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026